Clinical trial
A Prospective Open-label Non-randomized Pivotal Study to Evaluate the Safety and Performance of the Horizon™ Abdominal Aortic Aneurysm (AAA) Stent Graft System
NCT02087501 is registered in ClinicalTrials.gov with Endospan Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Open-label Non-randomized Pivotal Study to Evaluate the Safety and Performance of the Horizon™ Abdominal Aortic Aneurysm (AAA) Stent Graft System
- Lead sponsor
- Endospan Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- May 31, 2021
- Enrollment
- 30 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
aortoiliac aneurysms, infrarenal abdominal aortic aneurysms